COMPANY PROFILE

摘要

Your Premier CMO for Specialized Sterile Injectables Backed by over 90 years of experience in parenterals, Baxter’s BioPharma Solutions (BPS) business collaborates with pharmaceutical companies to support commercialization objectives for their molecules. BPS is a premier CMO with a focus on injectable pharmaceutical manufacturing designed to meet complex and traditional sterile manufacturing challenges with confidence of delivery, service, and integrity. BPS can support your pharmaceutical needs with a broad portfolio of sterile fill/finish production capabilities, and our reputation is built on the highquality products we manufacture for our clients in a cGMP environment. Our delivery systems include prefilled syringes, liquid/lyophilized vials, diluents for reconstitution, powder-filled vials, and sterile crystallization. Our drug categories include small molecules, biologics, vaccines, cytotoxics, highly potent compounds, and ADCs (antibody-drug conjugates). From formulation and development, through commercial launch, our extensive, customized support services can guide you through marketplace complexities, helping you achieve the full potential for your drug molecule. Whether you face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, risk mitigation concerns, or patent expiry challenges, we offer tailored and versatile solutions to help achieve your commercialization objectives.